Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation (Q83194112)
Jump to navigation
Jump to search
scientific article published on 13 January 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation |
scientific article published on 13 January 2009 |
Statements
Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation (English)
Konstantin J Dedes
Bernhard C Pestalozzi
Daniel Fink
Peter Brauchli
13 January 2009